Recent Headlines
Mitegen Appoints New CEO
Mitegen LLC (“Mitegen”, the “Company), a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced today that Robert Newman has been appointed... - January 19, 2011 - MiTeGen, LLC
Laboratory Robotics Interest Group (LRIG) Exhibits at LabAutomation
The Laboratory Robotics Interest Group (LRIG) is pleased to announce its participation in LabAutomation2011, January 29 - February 2, 2011, Palm Springs Convention Center, Palm Springs, California. All conferees, exhibitors, and media are invited to visit the LRIG booth, #492 to get the latest... - January 17, 2011 - Laboratory Robotics Interest Group (LRIG)
Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study
The principal investigator of the new colon cancer trial using Reolysin is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. - January 13, 2011 - Oncolytics Biotech
Pacific Biomarkers, Inc. Announces Awards of Major Research Contracts
Pacific Biomarkers, Inc. (OTCBB: PBMC, “PBI”), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the... - January 13, 2011 - Pacific Biomarkers Inc
MRSA Infected Mesh Successfully Treated with Triticum's L-Mesitran Honey Ointment
The overall reported percentage of mesh infections is 1.3%. Infections after incisional ventral hernia repair depend on many factors. Salvaging an infected mesh should be the priority, because serious complications are reported following mesh removal. Dr Chatzoulis et al. reports a case report and... - January 12, 2011 - Mesitran
ALPCO Appoints Cosmo Bio Co., Ltd. as Their New Distribution Channel in Japan
Cosmo Bio Co., Ltd. is a distributor of high quality research reagents and instruments throughout Japan. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - January 10, 2011 - ALPCO
Corengi Diabetes Clinical Trial Website Trades Facebook "Likes" for Donations to Dodging Diabetes® Charity
Corengi campaign helps patients living with Type 2 diabetes select clinical trials and supports diabetes research. - January 05, 2011 - Corengi, Inc.
Affinity Life Sciences Announces Expansion of Their cGMP Manufacturing Facility to Provide Additional Capacity for Biomarker Assay Development and Lyophilization Services
Affinity Life Sciences, Inc. is a New England based contract manufacturing and research organization committed to providing scientific and quality expertise to meet the unique production demands of the biotechnology and pharmaceutical industries worldwide. Affinity's introduction of this space allows for even greater capacity and efficiency for projects ranging from R&D to cGMP compliant production. - December 31, 2010 - Affinity Life Sciences
Achieve Clinical Research Announces Chronic Pain Research Studies in Birmingham, Alabama
Achieve Clinical Research conducts Phase II-IV clinical research studies on many conditions. Located in Birmingham, near Vestavia, Homewood, and North Jefferson. Participation can include medical care. - December 23, 2010 - Achieve Clinical Research
Latest Research Confirms That Triticum's L-Mesitran Honey Products Show Antibacterial Efficacy Against Antibiotic Resistant Bacteriae
Honey based products for wound care proved to be highly effective against strains of antibiotic bacteriae including ESBL. - December 16, 2010 - Mesitran
Achieve Clinical Research Announces Asthma Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with asthma. - December 12, 2010 - Achieve Clinical Research
Interest in Sclerostin as a Regulator of Bone Formation Remains High
Sclerostin, a protein produced primarily in osteocytes, inhibits osteoblast activity via antagonism of the wnt signaling pathway and, as such, has garnered a great deal of attention as a potential therapeutic target for increasing bone formation. The annual publication rate for peer-reviewed... - December 07, 2010 - ALPCO
Clinical Trials of America Opens New Site in Seattle and Names Kathy Hendricks as Manager
Clinical Trials of America Inc. has announced the opening of a new Seattle site and named Kathy Hendricks as site manager. Hendricks leads operational and business development and oversees patient recruitment and relations. “The opening of the Seattle site is the next phase of expansion for... - December 02, 2010 - Clinical Trials of America
Leeds Scientific to Unveil New Distributor Opportunities for Sculptisse
Leeds Scientific has patented their most popular product Sculptisse, and is now offering exclusive distributorships worldwide. - December 02, 2010 - Leeds Scientific
Leeds Scientific Wins Approval in France
Savvy French consumers and distributors alike have praised Sculptisse for having powerful results that safely and effectively eliminates wrinkles faster than most wrinkle creams on the market. - December 01, 2010 - Leeds Scientific
Medlabusa.com, STD Test & STD Testing with No Doctor’s Prescription
www.medlabusa.com, an online medical testing site, announced today that it has completed work and launched a new website, aimed at lowering rapidly escalating medical testing costs, with no doctor’s prescription. Doctor owned/operated www.medlabusa.com, is a new concept that allows anyone to... - November 30, 2010 - Medlabusa.com
Achieve Clinical Research Announces Irritable Bowel Syndrome Research Studies in Birmingham, Alabama
Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for those already diagnosed with irritable bowel syndrome (IBS). - November 24, 2010 - Achieve Clinical Research
Dilyx Launches New Kit for Improved Protein Solubility
Dilyx Biotechnologies, LLC announces the launch of the OptiSol Protein Solubility Screening Kit, allowing research scientists to aggregation-proof their protein samples. The resulting data saves effort and money because it informs life science researchers on how to best treat specific samples for storage or analysis. Find more information at www.dilyx.com - November 19, 2010 - Dilyx Biotechnologies
Calvert Research Awarded Federal Grants Totaling Approximately $245,000 to Support Further Development of Its Age-Related Macular Degeneration Drug Candidate
Calvert Research, LLC announced today that one of the Company’s therapeutic development programs (T1-1081) qualified to receive federal grant funding totaling approximately $245,000 under the Patient Protection and Affordable Care Act of 2010 (“The ACT”), which will be used to... - November 17, 2010 - Calvert Research
Achieve Clinical Research Announces Influenza Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with influenza. - November 14, 2010 - Achieve Clinical Research
NanoCor Therapeutics, Inc. is Awarded a Grant Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
NanoCor Therapeutics, Inc. (NanoCor) today announced the Company was awarded a grant under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP). The grant is being provided under section 48D of the Internal Revenue Code, enacted as part of the Patient Protection and Affordable Care... - November 08, 2010 - NanoCor Therapeutics Inc.
Colorado’s Bioscience Industry Awarded Over $23 Million in Funding from Federal Qualifying Therapeutic Discovery Project Grant and Tax Credit Program
According to the Colorado BioScience Association (CBSA), Colorado’s bioscience industry received more than $23 million for 102 different projects in the Qualifying Therapeutic Discovery Project (QTDP) program, per data posted online Monday by the Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services (HHS). Colorado ranks in the top ten of states applying for credits and grants under the new program. - November 06, 2010 - Colorado BioScience Association
Clinical Trials of America, Inc., Participating in Pivotal Clinical Study of Novel Treatment for Type 1 Diabetes
Defend-2 Evaluating Drug Candidate, Otelixizumab, in New-Onset Type 1 Diabetes. - November 06, 2010 - Clinical Trials of America
Clinical Trials of America Names Pamela Pannier Clinical Operations Director
Pamela Pannier has joined Clinical Trials of America, Inc., as the company’s clinical operations director. Pannier will lead business development, including sourcing, managing and implementing new business opportunities in the Eugene and surrounding areas. “Pamela Pannier brings almost... - November 06, 2010 - Clinical Trials of America
Achieve Clinical Research Announces Osteoarthritis (OA) Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with osteoarthritis (OA). - November 05, 2010 - Achieve Clinical Research
Patients Use More Specific Keywords While Seeking Clinical Trial Information Online, According to TrialX Research
A new research study finds that e-patients searching for health information related to clinical research studies tend to use longer and more specific keywords - November 04, 2010 - Applied Informatics
Revolutionary Vbeam® Perfecta Laser Treatment for Rosacea and Facial Veins
The Vbeam® Perfecta sets the gold standard in treatment of facial redness such as rosacea and facial veins. It is highly recommended for unsightly broken capillaries, spider hemangioms, telangectasia or skin discoloration on the face. - November 04, 2010 - Abrams Dermatology
Corengi Launches New Web Site to Help Type 2 Diabetes Patients Find Suitable Clinical Trials
www.corengi.com simplifies the clinical trial selection process; enables type 2 diabetes patients to learn which trials are right for them. - October 28, 2010 - Corengi, Inc.
The Colorado BioScience Association and 650+ Partners Oppose Amendments 60 and 61 & Proposition 101
The Colorado BioScience Association along with over 650 partners are opposed to three ballot measures facing Colorado this election – Amendment 60, Amendment 61 and Proposition 101. These three measures - also known as the 'ugly three' - are referred to as tax breaks, but will have a devastating impact on Colorado and the companies located in the state for years to come. - October 27, 2010 - Colorado BioScience Association
Stemedica International Announces Joint Venture with AnC Bio Group to Manufacture Allogeneic Adult Stem Cells
Stemedica International, S.A., a wholly owned subsidiary of Stemedica Cell Technologies, Inc., announced the signing of an agreement to form a joint venture with AnC Bio, a global manufacturer of stem cell-based products. The new venture, StemedicaAnC, will manufacture allogeneic adult stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders. - October 24, 2010 - Stemedica Cell Techechnologies
Clinical Trials of America Announces Don Dickerson as President
Donald Dickerson, experienced business leader and clinical studies manager, joins Clinical Trials of America as the company’s new president. Dickerson, who has developed and advanced profitable companies and divisions in global health, technology, and financial service, now manages all... - October 22, 2010 - Clinical Trials of America
Colorado BioScience Association and Two of the State’s Economic Development Entities, Tout Colorado’s Strengths at AdvaMed 2010
Representatives from the Colorado BioScience Association, Colorado Office of Economic Development and International Trade and Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostics sectors during the 2010 AdvaMed: The MedTech Conference in Washington D.C., October 18-20. - October 20, 2010 - Colorado BioScience Association
Clinical Trials of America’s CEO & Chief Medical Officer Presents at MAGI’s Clinical Research Conference – 2010 West
Dr. Richard Beyerlein explains how to be a clinical researcher’s “sponsor of choice.” - October 16, 2010 - Clinical Trials of America
Stemedica Announces Completion of Clinical Allogeneic Adult Stem Cell Master Bank
A world leader in allogeneic adult stem cell manufacturing and research, Stemedica Cell Technologies, Inc. announced the completion of its proprietary master bank of mesenchymal bone marrow-derived stem cells. - October 15, 2010 - Stemedica Cell Techechnologies
Achieve Clinical Research Announces Rheumatoid Arthritis Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with rheumatoid arthritis. - October 14, 2010 - Achieve Clinical Research
Creativ-Ceutical to be Centre Stage at ISPOR Europe 2010
Strengthening its positioning as one of the major pan-European consulting companies in pricing, market access and health economics, Creativ-Ceutical will be present in force at ISPOR 2010 from 6-9 November in Prague. - October 13, 2010 - Creativ-Ceutical
Optasia Medical to Demonstrate Innovative X-Ray Analysis Capabilities at Leading Industry Events
Optasia Medical introduces powerful new clinical workflow tools for the interpretation of x-rays for osteoporosis and arthritis - October 12, 2010 - Optasia Medical, Ltd.
Colorado BioScience Association Announces Winners of Its 2010 Awards, Honoring The Best of Colorado's Bioscience Industry
The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 2010 Annual Awards Dinner held in conjunction with the BioWest Conference & Expo at the Denver Grand Hyatt. The Annual Awards Dinner gives CBSA the ability to showcase companies and individuals that have had an outstanding year and to celebrate the industry as a whole. - October 11, 2010 - Colorado BioScience Association
IonSense Expands Product Line with ASAP Open-Air Ionization Source
IonSense to sell Atmospheric Solids Analysis Probe (ASAP) as Entry Level Source for Open-Air Mass Spectrometry - October 08, 2010 - IonSense, Inc.
Adaptive Site Monitoring Improves Clinical Research Efficiency: DIA Invites Health Decisions to Discuss
Health Decisions CEO Dr. Michael Rosenberg will explore the implications of advanced e-monitoring models during two sessions at the DIA 4th Annual Clinical Forum. - October 08, 2010 - Health Decisions
Introducing Professional PDT from Medik8
Light Amplifier™ RX has been formulated by Medik8 scientists to boost the clinically proven results from increasingly popular light therapy. This novel and unique lightweight 20% strength serum is applied prior to light therapy procedures in-clinic and dramatically increases efficacy of all light-based hardware regardless of manufacturer; a retail version is also available for at-home use with a personal light therapy lamp. - October 06, 2010 - Pangaea Ltd.
Is Medik8® Now Chasing Men with Its Oil-Free Antioxidant Blue Aox™?
Medik8 Skin Research has developed Blue AOX™; a powerful antioxidant serum to put skin aging on hold. - October 06, 2010 - Pangaea Ltd.
New to the Medik8 Beta Range – The Anti-Acne Kit
The Medik8 “beta” range is constantly evolving, with 2010 proving to be a pivotal year in the maturing of this award-winning line for problem skin. September 2010 sees the launch of the brand new Anti-Acne Kit. Combining state of the art formulations with on the pulse market focus, Medik8 have designed two unique products to create a convenient dual treatment pack. - October 06, 2010 - Pangaea Ltd.
Innovative Technology for Skin Rejuvenation Therapy-Medik8 Launches Titanium Dermastamp
Medik8 Skin Research is launching a clever, new skin needling device to expand its current skin needling range. - October 05, 2010 - Pangaea Ltd.
Health Decisions CEO to Address Adaptive Patient Enrollment at Achieving Operational Efficiency in Clinical Trials 2010
Dr. Michael Rosenberg will discuss how continuously adapting enrollment during studies prevents delays and setbacks. - October 03, 2010 - Health Decisions
BJS Biotechnologies Launches UF1 at Biotechnica
Ultra-rapid next-generation thermal cycler could bring PCR to point-of-care - October 03, 2010 - BJS Biotechnologies Ltd
Sharklet Technologies Wins Dorsey & Whitney Venture Showcase Award, Presented at 2010 BioWest Conference & Expo
Sharklet Technologies, Inc., has won the Dorsey & Whitney Venture Showcase Award at the 2010 BioWest Conference & Expo in Denver. The announcement is made by Holli Baumunk, President & CEO of the Colorado BioScience Association (CBSA), who says the $7,500 Venture Showcase award was provided by the Dorsey & Whitney law firm and announced at the 2010 CBSA Awards Dinner. - October 02, 2010 - Colorado BioScience Association
OSO BioPharmaceuticals Appoints Susan Schniepp VP of Quality
OSO BioPharmaceuticals Manufacturing, LLC, has named Susan Schniepp as vice president of quality. In managing all operational quality-related issues, Schniepp is responsible for cGMP compliance of OsoBio’s facility. Quality-related matters concerning validation as well as regulatory affairs,... - September 30, 2010 - OSO BioPharmaceuticals Manufacturing, LLC
Mercodia Will Market Their Oxidized LDL ELISA as an In-vitro Diagnostic for Clinical Use
The United States Food and Drug Administration (FDA) has determined that the Mercodia Oxidized LDL ELISA can be used clinically as an IVD. Oxidized LDL has been shown to play a key role in the initiation and progression of atherosclerosis, making the Mercodia Oxidized LDL ELISA a critical biomarker in cardiovascular disease-related studies and the most widely used method commercially available today. - September 27, 2010 - Mercodia Inc.
DNA Diagnostics Centre (DDC) Opens Their 4,000th Worldwide DNA Testing Sample Collection Centre
DDC testing laboratory expands its worldwide network by adding new DNA sample collection facilities. - September 27, 2010 - DNA Diagnostics Centre